Skip to main content
SpringerLink
Log in

The Cross-Talk between Epigenetic Gene Regulation and Signaling Pathways Regulates Cancer Pathogenesis

  • Chapter
  • First Online:
Metabolism and Epigenetic Regulation: Implications in Cancer

Part of the book series: Subcellular Biochemistry ((SCBI,volume 100))

Abstract

Cancer begins due to uncontrolled cell division. Cancer cells are insensitive to the signals that control normal cell proliferation. This uncontrolled cell division is due to the accumulation of abnormalities in different factors associated with the cell division, including different cyclins, cell cycle checkpoint inhibitors, and cellular signaling. Cellular signaling pathways are aberrantly activated in cancer mainly due to epigenetic regulation and post-translational regulation. In this chapter, the role of epigenetic regulation in aberrant activation of PI3K/AKT, Ras, Wnt, Hedgehog, Notch, JAK/STAT, and mTOR signaling pathways in cancer progression is discussed. The role of epigenetic regulators in controlling the upstream regulatory proteins and downstream effector proteins responsible for abnormal cellular signaling-mediated cancer progression is covered in this chapter. Similarly, the role of signaling pathways in controlling epigenetic gene regulation-mediated cancer progression is also discussed. We have tried to ascertain the current status of potential epigenetic drugs targeting several epigenetic regulators to prevent different cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aithal MG, Rajeswari N (2013 Dec) Role of Notch signalling pathway in cancer and its association with DNA methylation. J Genet 92(3):667-675. https://doi.org/10.1007/s12041-013-0284-5. PMID: 24371188

  • Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M, Issa JP, Hinoda Y, Imai K, Tokino T (2005 Jul) The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129(1):156-169. https://doi.org/10.1053/j.gastro.2005.03.051. PMID: 16012945

  • Andersson ER, Sandberg R, Lendahl U (2011 Sep) Notch signaling: simplicity in design, versatility in function. Development 138(17):3593-3612. https://doi.org/10.1242/dev.063610. PMID: 21828089

  • Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA (1999 Jun 4) Interaction of frizzled-related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem 274(23):16180-16187. https://doi.org/10.1074/jbc.274.23.16180. PMID: 10347172

  • Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM (2006 Apr 21) Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun 342(4):1228-1232. https://doi.org/10.1016/j.bbrc.2006.02.084. Epub 2006 Feb 24. PMID: 16516163

  • Benard A, Goossens-Beumer IJ, van Hoesel AQ, de Graaf W, Horati H, Putter H, Zeestraten EC, van de Velde CJ, Kuppen PJ (2014 Jul 22) Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer. BMC Cancer 14:531. https://doi.org/10.1186/1471-2407-14-531. PMID: 25047223; PMCID: PMC4223547

  • Bhadury J, Nilsson LM, Muralidharan SV, Green LC, Li Z, Gesner EM, Hansen HC, Keller UB, McLure KG, Nilsson JA (2014 Jul 1) BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma. Proc Natl Acad Sci U S A 111(26):E2721-30. https://doi.org/10.1073/pnas.1406722111. Epub 2014 Jun 16. PMID: 24979794; PMCID: PMC4084424

  • Bhagat TD, Zou Y, Huang S, Park J, Palmer MB, Hu C, Li W, Shenoy N, Giricz O, Choudhary G, Yu Y, Ko YA, Izquierdo MC, Park AS, Vallumsetla N, Laurence R, Lopez R, Suzuki M, Pullman J, Kaner J, Gartrell B, Hakimi AA, Greally JM, Patel B, Benhadji K, Pradhan K, Verma A, Susztak K (2017 Jan 20) Notch pathway is activated via genetic and epigenetic alterations and is a therapeutic target in clear cell renal cancer. J Biol Chem. 292(3):837-846. https://doi.org/10.1074/jbc.M116.745208. Epub 2016 Dec 1. PMID: 27909050; PMCID: PMC5247657

  • Bird A (2002 Jan 1) DNA methylation patterns and epigenetic memory. Genes Dev. 16(1):6-21. https://doi.org/10.1101/gad.947102. PMID: 11782440

  • Bucci C, Chiariello M (2006 Jan) Signal transduction gRABs attention. Cell Signal. 18(1):1-8. https://doi.org/10.1016/j.cellsig.2005.07.001. Epub 2005 Aug 9. PMID: 16084065

  • Cadigan KM, Nusse R (1997 Dec 15) Wnt signaling: a common theme in animal development. Genes Dev. 11(24):3286-3305. https://doi.org/10.1101/gad.11.24.3286. PMID: 9407023

  • Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM, Morton DG (2004 Feb 1) The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64(3):883-888. https://doi.org/10.1158/0008-5472.can-03-1346. PMID: 14871816

  • Canon J, Rex K, Saiki AY, Mohr C, Cooke K, Bagal D, Gaida K, Holt T, Knutson CG, Koppada N, Lanman BA, Werner J, Rapaport AS, San Miguel T, Ortiz R, Osgood T, Sun JR, Zhu X, McCarter JD, Volak LP, Houk BE, Fakih MG, O’Neil BH, Price TJ, Falchook GS, Desai J, Kuo J, Govindan R, Hong DS, Ouyang W, Henary H, Arvedson T, Cee VJ, Lipford JR (2019 Nov) The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575(7781):217-223. https://doi.org/10.1038/s41586-019-1694-1. Epub 2019 Oct 30. PMID: 31666701

  • Cao R, Tsukada Y, Zhang Y (2005 Dec 22) Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 20(6):845-854. https://doi.org/10.1016/j.molcel.2005.12.002. PMID: 16359901

  • Chan E, Luwor R, Burns C, Kannourakis G, Findlay JK, Ahmed N (2018 Mar 30) Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer. Oncotarget 9(24):16599-16618. https://doi.org/10.18632/oncotarget.24615. PMID: 29682172; PMCID: PMC5908273

  • Chen W, Tang T, Eastham-Anderson J, Dunlap D, Alicke B, Nannini M, Gould S, Yauch R, Modrusan Z, DuPree KJ, Darbonne WC, Plowman G, de Sauvage FJ, Callahan CA (2011 Jun 7) Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci U S A. 108(23):9589-94. https://doi.org/10.1073/pnas.1017945108. Epub 2011 May 19. PMID: 21597001; PMCID: PMC3111273

  • Chen L, Tang J, Feng Y, Li S, Xiang Q, He X, Ren G, Peng W, Xiang T (2017) ADAMTS9 is silenced by epigenetic disruption in colorectal cancer and inhibits cell growth and metastasis by regulating Akt/p53 signaling. Cell Physiol Biochem. 44(4):1370-1380. https://doi.org/10.1159/000485534. Epub 2017 Nov 30. PMID: 29186710

  • Choi HS, Kim SL, Kim JH, Lee DS (2020 Feb 4). The FDA-approved anti-asthma medicine ciclesonide inhibits lung cancer stem cells through hedgehog signaling-mediated SOX2 regulation. Int J Mol Sci. 21(3):1014. https://doi.org/10.3390/ijms21031014. PMID: 32033067; PMCID: PMC7038186

  • Collett K, Eide GE, Arnes J, Stefansson IM, Eide J, Braaten A, Aas T, Otte AP, Akslen LA (2006 Feb 15) Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. Clin Cancer Res 12(4):1168-1174. https://doi.org/10.1158/1078-0432.CCR-05-1533. PMID: 16489070

  • Cui Y, Ma W, Lei F, Li Q, Su Y, Lin X, Lin C, Zhang X, Ye L, Wu S, Li J, Yuan Z, Song L (2016 Jul) Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling. J Pathol 239(3):297-308. https://doi.org/10.1002/path.4725. Epub 2016 May 30. PMID: 27060981

  • Dao KT, Gotlib J, Deininger MMN, Oh ST, Cortes JE, Collins RH Jr, Winton EF, Parker DR, Lee H, Reister A, Schultz, Savage S, Stevens, Brockett C, Subbiah N, Press RD, Raess PW, Cascio M, Dunlap J, Chen Y, Degnin C, Maxson JE, Tognon CE, Macey T, Druker BJ, Tyner JW (2020 Apr 1) Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia. J Clin Oncol 38(10):1006-1018. https://doi.org/10.1200/JCO.19.00895. Epub 2019 Dec 27. PMID: 31880950; PMCID: PMC7106977

  • Das S, Morvan F, Morozzi G, Jourde B, Minetti GC, Kahle P, Rivet H, Brebbia P, Toussaint G, Glass DJ, Fornaro M. ATP citrate lyase regulates myofiber differentiation and increases regeneration by altering histone acetylation. Cell Rep. 2017 Dec 12;21(11):3003-3011. https://doi.org/10.1016/j.celrep.2017.11.038. PMID: 29241530

  • Deshpande I, Liang J, Hedeen D, Roberts KJ, Zhang Y, Ha B, Latorraca NR, Faust B, Dror RO, Beachy PA, Myers BR, Manglik A (2019 Jul) Smoothened stimulation by membrane sterols drives Hedgehog pathway activity. Nature 571(7764):284-288. https://doi.org/10.1038/s41586-019-1355-4. Epub 2019 Jul 1. PMID: 31263273; PMCID: PMC6709672

  • Du W, Wang S, Zhou Q, Li X, Chu J, Chang Z, Tao Q, Ng EK, Fang J, Sung JJ, Yu J (2013 Jul 11) ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer. Oncogene. 32(28):3319-28. https://doi.org/10.1038/onc.2012.359. Epub 2012 Aug 20. PMID: 22907434

  • Duan ZH, Wang HC, Zhao DM, Ji XX, Song M, Yang XJ, Cui W (2015 Aug) Cooperatively transcriptional and epigenetic regulation of sonic hedgehog overexpression drives malignant potential of breast cancer. Cancer Sci 106(8):1084–1091. https://doi.org/10.1111/cas.12697. Epub 2015 Jul 25. PMCID: PMC4556399

  • Dumitrescu RG (2018) Early epigenetic markers for precision medicine. Methods Mol Biol 1856:3-17. https://doi.org/10.1007/978-1-4939-8751-1_1. PMID: 30178243

  • Duruisseaux M, Esteller M (2018 Aug) Lung cancer epigenetics: from knowledge to applications. Semin Cancer Biol 51:116-128. https://doi.org/10.1016/j.semcancer.2017.09.005. Epub 2017 Sep 14. PMID: 28919484

  • Ecke I, Petry F, Rosenberger A, Tauber S, Mönkemeyer S, Hess I, Dullin C, Kimmina S, Pirngruber J, Johnsen SA, Uhmann A, Nitzki F, Wojnowski L, Schulz-Schaeffer W, Witt O, Hahn H (2009 Feb 1) Antitumor effects of a combined 5-aza-2′deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Cancer Res 69(3):887-895. https://doi.org/10.1158/0008-5472.CAN-08-0946. Epub 2009 Jan 20. PMID: 19155313

  • Ehmann F, Horn S, Garcia-Palma L, Wegner W, Fiedler W, Giehl K, Mayr GW, Jücker M (2006 Jul) Detection of N-RAS and K-RAS in their active GTP-bound form in acute myeloid leukemia without activating RAS mutations. Leuk Lymphoma 47(7):1387-1391. https://doi.org/10.1080/10428190600565925. PMID: 16923573

  • Estève PO, Chin HG, Benner J, Feehery GR, Samaranayake M, Horwitz GA, Jacobsen SE, Pradhan S (2009 Mar 31) Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci U S A 106(13):5076-81. https://doi.org/10.1073/pnas.0810362106. Epub 2009 Mar 12. PMID: 19282482; PMCID: PMC2654809

  • Estève PO, Chang Y, Samaranayake M, Upadhyay AK, Horton JR, Feehery GR, Cheng X, Pradhan S (2011 Jan) A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability. Nat Struct Mol Biol 18(1):42-8. https://doi.org/10.1038/nsmb.1939. Epub 2010 Dec 12. PMID: 21151116; PMCID: PMC3048033

  • Fang QL, Yin YR, Xie CR, Zhang S, Zhao WX, Pan C, Wang XM, Yin ZY (2015 Feb) Mechanistic and biological significance of DNA methyltransferase 1 upregulated by growth factors in human hepatocellular carcinoma. Int J Oncol 46(2):782-790. doi: https://doi.org/10.3892/ijo.2014.2776. Epub 2014 Nov 24. PMID: 25420499

  • Fang M, Hutchinson L, Deng A, Green MR (2016 Feb 2) Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma. Proc Natl Acad Sci U S A 113(5):1250-5. https://doi.org/10.1073/pnas.1525619113. Epub 2016 Jan 19. PMID: 26787892; PMCID: PMC4747705

  • Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H (2020 Dec 1) PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci 262:118513. https://doi.org/10.1016/j.lfs.2020.118513. Epub 2020 Oct 1. PMID: 33011222

  • Fenton RG, Hixon JA, Wright PW, Brooks AD, Sayers TJ (1998 Aug 1) Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras. Cancer Res 58(15):3391-3400. PMID: 9699671

    Google Scholar 

  • Ferres-Marco D, Gutierrez-Garcia I, Vallejo DM, Bolivar J, Gutierrez-Aviño FJ, Dominguez M (2006 Jan 26) Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing. Nature 439(7075):430-436. https://doi.org/10.1038/nature04376. PMID: 16437107

  • Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017 Aug 10) The PI3K pathway in human disease. Cell 170(4):605-635. https://doi.org/10.1016/j.cell.2017.07.029. PMID: 28802037; PMCID: PMC5726441

  • Frye R, Myers M, Axelrod KC, Ness EA, Piekarz RL, Bates SE, Booher S (2012 Apr) Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma. Clin J Oncol Nurs 16(2):195-204. https://doi.org/10.1188/12.CJON.195-204. PMID: 22459529; PMCID: PMC7243910

  • Fu DY, Wang ZM, Li-Chen, Wang BL, Shen ZZ, Huang W, Shao ZM (2010 Feb) Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Breast Cancer Res Treat 119(3):601-612. https://doi.org/10.1007/s10549-009-0339-8. Epub 2009 Mar 20. PMID: 19301122

  • Fukui T, Kondo M, Ito G, Maeda O, Sato N, Yoshioka H, Yokoi K, Ueda Y, Shimokata K, Sekido Y (2005 Sep 15) Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 24(41):6323-6327. https://doi.org/10.1038/sj.onc.1208777. PMID: 16007200

  • Gabata R, Harada K, Mizutani Y, Ouchi H, Yoshimura K, Sato Y, Kitao A, Kimura K, Kouji H, Miyashita T, Tajima H, Ohta T (2020 Sep) Anti-tumor activity of the small molecule inhibitor PRI-724 against β-Catenin-activated Hepatocellular Carcinoma. Anticancer Res. 40(9):5211-5219. https://doi.org/10.21873/anticanres.14524. PMID: 32878809

  • García JM, Silva J, Peña C, Garcia V, Rodríguez R, Cruz MA, Cantos B, Provencio M, España P, Bonilla F (2004 Oct) Promoter methylation of the PTEN gene is a common molecular change in breast cancer. Genes Chromosomes Cancer 41(2):117-124. https://doi.org/10.1002/gcc.20062. PMID: 15287024

  • Garten A, Grohmann T, Kluckova K, Lavery GG, Kiess W, Penke M (2019 Aug 19) Sorafenib-induced apoptosis in hepatocellular carcinoma is reversed by SIRT1. Int J Mol Sci 20(16):4048. https://doi.org/10.3390/ijms20164048. PMID: 31430957; PMCID: PMC6719220

  • Gazin C, Wajapeyee N, Gobeil S, Virbasius CM, Green MR (2007 Oct 25) An elaborate pathway required for Ras-mediated epigenetic silencing. Nature 449(7165):1073-7. https://doi.org/10.1038/nature06251. PMID: 17960246; PMCID: PMC2147719

  • Giehl K (2005 Mar) Oncogenic Ras in tumour progression and metastasis. Biol Chem 386(3):193-205. https://doi.org/10.1515/BC.2005.025. PMID: 15843165

  • Goel A, Arnold CN, Niedzwiecki D, Carethers JM, Dowell JM, Wasserman L, Compton C, Mayer RJ, Bertagnolli MM, Boland CR (2004 May 1) Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 64(9):3014-3021. https://doi.org/10.1158/0008-5472.can-2401-2. PMID: 15126336

  • Gonzalez ME, DuPrie ML, Krueger H, Merajver SD, Ventura AC, Toy KA, Kleer CG (2011 Mar 15) Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer. Cancer Res 71(6):2360-70. https://doi.org/10.1158/0008-5472.CAN-10-1933. PMID: 21406404; PMCID: PMC3071296

  • Gopal U, Pizzo SV (2017 Nov 14) Cell surface GRP78 promotes tumor cell histone acetylation through metabolic reprogramming: a mechanism which modulates the Warburg effect. Oncotarget 8(64):107947-107963. https://doi.org/10.18632/oncotarget.22431. PMID: 29296215; PMCID: PMC5746117

  • Gräff J, Tsai LH (2013 Feb) Histone acetylation: molecular mnemonics on the chromatin. Nat Rev Neurosci 14(2):97-111. https://doi.org/10.1038/nrn3427. Epub 2013 Jan 17. PMID: 23324667

  • Grunstein M (1997 Sep 25) Histone acetylation in chromatin structure and transcription. Nature 389(6649):349-352. https://doi.org/10.1038/38664. PMID: 9311776

  • Guo P, Hu T, Zhang J, Jiang S, Wang X (2010 Oct 19) Sequential action of Caenorhabditis elegans Rab GTPases regulates phagolysosome formation during apoptotic cell degradation. Proc Natl Acad Sci U S A 107(42):18016-21. https://doi.org/10.1073/pnas.1008946107. Epub 2010 Oct 4. PMID: 20921409; PMCID: PMC2964220

  • Guo J, Dai X, Laurent B, Zheng N, Gan W, Zhang J, Guo A, Yuan M, Liu P, Asara JM, Toker A, Shi Y, Pandolfi PP, Wei W (2019 Feb) AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions. Nat Cell Biol 21(2):226-237. https://doi.org/10.1038/s41556-018-0261-6. Epub 2019 Jan 28. PMID: 30692625; PMCID: PMC6377565

  • Haldrup C, Pedersen AL, Øgaard N, Strand SH, Høyer S, Borre M, Ørntoft TF, Sørensen KD (2018 Apr) Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies. Mol Oncol 12(4):545-560. https://doi.org/10.1002/1878-0261.12183. Epub 2018 Mar 13. PMID: 29465788; PMCID: PMC5891052

  • Hegi ME, Liu L, Herman JG, Stupp R, Wick W, Weller M, Mehta MP, Gilbert MR (2008 Sep 1) Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity. J Clin Oncol 26(25):4189-4199. https://doi.org/10.1200/JCO.2007.11.5964. PMID: 18757334

  • Heitzer E, Bambach I, Dandachi N, Horn M, Wolf P (2010 Oct) PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches. Exp Dermatol 19(10):926-8. https://doi.org/10.1111/j.1600-0625.2010.01120.x. Epub 200 Aug 31. PMID: 20849535

  • Hervouet E, Lalier L, Debien E, Cheray M, Geairon A, Rogniaux H, Loussouarn D, Martin SA, Vallette FM, Cartron PF (2010 Jun 29) Disruption of Dnmt1/PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS One 5(6):e11333. https://doi.org/10.1371/journal.pone.0011333. PMID: 20613874; PMCID: PMC2894052

  • Hodge DR, Cho E, Copeland TD, Guszczynski T, Yang E, Seth AK, Farrar WL (2007 Nov-Dec) IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics 4(6):387-398. PMID: 18204201

    Google Scholar 

  • Holliday R (1994) Epigenetics: an overview. Dev Genet 15(6):453-457. https://doi.org/10.1002/dvg.1020150602. PMID: 7834903

  • Hori K, Sen A, Artavanis-Tsakonas S (2013 May 15). Notch signaling at a glance. J Cell Sci. 126(Pt 10):2135-40. https://doi.org/10.1242/jcs.127308. Epub 2013 May 31. PMID: 23729744; PMCID: PMC3672934

  • Huang WC, Chen CC (2005 Aug) Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol Cell Biol 25(15):6592-602. https://doi.org/10.1128/MCB.25.15.6592-6602.2005. PMID: 16024795; PMCID: PMC1190347

  • Hubmann R, Schnabl S, Araghi M, Schmidl C, Rendeiro AF, Hilgarth M, Demirtas D, Ali F, Staber PB, Valent P, Zielinski C, Jäger U, Shehata M (2020 Jun 18) Targeting nuclear NOTCH2 by gliotoxin recovers a tumor-suppressor NOTCH3 activity in CLL. Cells 9(6):1484. https://doi.org/10.3390/cells9061484. PMID: 32570839; PMCID: PMC7348714

  • Hudlebusch HR, Santoni-Rugiu E, Simon R, Ralfkiær E, Rossing HH, Johansen JV, Jørgensen M, Sauter G, Helin K (2011 May 1) The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res 17(9):2919-2933. https://doi.org/10.1158/1078-0432.CCR-10-1302. Epub 2011 Mar 8.

  • Hui M, Cazet A, Nair R, Watkins DN, O’Toole SA, Swarbrick A (2013 Mar 28) The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast Cancer Res 15(2):203. https://doi.org/10.1186/bcr3401. PMID: 23547970; PMCID: PMC3672663

  • Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M (1999 Jan 14) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397(6715):164-168. https://doi.org/10.1038/16476. PMID: 9923679

  • Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, Cheyette BN, Yu Q (2008 Jun) DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. Cancer Cell 13(6):529-41. https://doi.org/10.1016/j.ccr.2008.04.019. PMID: 18538736; PMCID: PMC2577847

  • Jones PA, Liang G (2009 Nov) Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 10(11):805-11. https://doi.org/10.1038/nrg2651. Epub 2009 Sep 30. PMID: 19789556; PMCID: PMC2848124.

  • Jones PA, Issa JP, Baylin S (2016 Sep 15) Targeting the cancer epigenome for therapy. Nat Rev Genet 17(10):630-641. https://doi.org/10.1038/nrg.2016.93. PMID: 27629931

  • Kang YH, Lee HS, Kim WH (2002 Mar) Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest 82(3):285-291. https://doi.org/10.1038/labinvest.3780422. PMID: 11896207

  • Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, Byun DS, Chae KS, Lee BH, Chun HS, Lee KY, Kim HJ, Chi SG (2008 Dec) NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Gastroenterology 135(6):2030-42, 2042.e1-3. https://doi.org/10.1053/j.gastro.2008.08.009. Epub 2008 Aug 20. PMID: 18824170

  • Kanouni T, Severin C, Cho RW, Yuen NY, Xu J, Shi L, Lai C, Del Rosario JR, Stansfield RK, Lawton LN, Hosfield D, O’Connell S, Kreilein MM, Tavares-Greco P, Nie Z, Kaldor SW, Veal JM, Stafford JA, Chen YK (2020 Dec 10) Discovery of CC-90011: a potent and selective reversible inhibitor of lysine specific demethylase 1 (LSD1). J Med Chem 63(23):14522-14529. https://doi.org/10.1021/acs.jmedchem.0c00978. Epub 2020 Oct 9. PMID: 33034194

  • Kasprzak A, Adamek A (2019 Oct 3) Insulin-like growth factor 2 (IGF2) signaling in colorectal cancer-from basic research to potential clinical applications. Int J Mol Sci 20(19):4915. https://doi.org/10.3390/ijms20194915. PMID: 31623387; PMCID: PMC6801528

  • Katoh Y, Katoh M. Comparative genomics on Sonic hedgehog orthologs. Oncol Rep. 2005 Oct;14(4):1087-1090. PMID: 16142377

    Google Scholar 

  • Kawano Y, Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci. 2003 Jul 1;116(Pt 13):2627-2634. https://doi.org/10.1242/jcs.00623. PMID: 12775774

  • Kelwick R, Desanlis I, Wheeler GN, Edwards DR (2015 May 30) The ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol 16(1):113. https://doi.org/10.1186/s13059-015-0676-3. PMID: 26025392; PMCID: PMC4448532

  • Kim JT, Li J, Jang ER, Gulhati P, Rychahou PG, Napier DL, Wang C, Weiss HL, Lee EY, Anthony L, Townsend CM Jr, Liu C, Evers BM (2013 May) Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors. Carcinogenesis 34(5):953-61. https://doi.org/10.1093/carcin/bgt018. Epub 2013 Jan 25. PMID: 23354304; PMCID: PMC3643417

  • Kim BK, Yoo HI, Kim I, Park J, Kim Yoon S (2015 Jun) FZD6 expression is negatively regulated by miR-199a-5p in human colorectal cancer. BMB Rep 48(6):360-6. https://doi.org/10.5483/bmbrep.2015.48.6.031. PMID: 25772759; PMCID: PMC4578624

  • Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM (2003 Sep 30) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 100(20):11606-11. https://doi.org/10.1073/pnas.1933744100. Epub 2003 Sep 19. PMID: 14500907; PMCID: PMC208805

  • Koinuma K, Yamashita Y, Liu W, Hatanaka H, Kurashina K, Wada T, Takada S, Kaneda R, Choi YL, Fujiwara SI, Miyakura Y, Nagai H, Mano H (2006 Jan 5) Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene. 25(1):139-146. https://doi.org/10.1038/sj.onc.1209009. PMID: 16247484

  • Kraus C, Liehr T, Hülsken J, Behrens J, Birchmeier W, Grzeschik KH, Ballhausen WG (1994 Sep 1) Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 23(1):272-274. https://doi.org/10.1006/geno.1994.1493. PMID: 7829088

  • Kuang SQ, Fang Z, Zweidler-McKay PA, Yang H, Wei Y, Gonzalez-Cervantes EA, Boumber Y, Garcia-Manero G (2013 Apr 26) Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia. PLoS One 8(4):e61807. https://doi.org/10.1371/journal.pone.0061807. PMID: 23637910; PMCID: PMC3637323

  • Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomäki P (2000 May) Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 156(5):1773-9. https://doi.org/10.1016/S0002-9440(10)65048-1. PMID: 10793088; PMCID: PMC1876911

  • Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, Worth AJ, Yuan ZF, Lim HW, Liu S, Jackson E, Aiello NM, Haas NB, Rebbeck TR, Judkins A, Won KJ, Chodosh LA, Garcia BA, Stanger BZ, Feldman MD, Blair IA, Wellen KE (2014 Aug 5) Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab 20(2):306-319. https://doi.org/10.1016/j.cmet.2014.06.004. Epub 2014 Jul 3. PMID: 24998913; PMCID: PMC4151270

  • Li Q, Li Y, Gu B, Fang L, Zhou P, Bao S, Huang L, Dai X (2015 Aug 28) Akt phosphorylates Wnt coactivator and chromatin effector Pygo2 at serine 48 to antagonize its ubiquitin/proteasome-mediated degradation. J Biol Chem 290(35):21553-67. https://doi.org/10.1074/jbc.M115.639419. Epub 2015 Jul 13. PMID: 26170450; PMCID: PMC4571880

  • Li N, Xue W, Yuan H, Dong B, Ding Y, Liu Y, Jiang M, Kan S, Sun T, Ren J, Pan Q, Li X, Zhang P, Hu G, Wang Y, Wang X, Li Q, Qin J (2017 Apr 3) AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis. J Clin Invest 127(4):1284-1302. https://doi.org/10.1172/JCI91144. Epub 2017 Mar 20. PMID: 28319045; PMCID: PMC5373871

  • Lian H, Jia X, Shi N, Xie S, Wang J, Wang W, Ma F, Liu H, Wang A, Cheng X, Liu C (2018 Nov 22) Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4. Cancer Manag Res 10:6129-6141. https://doi.org/10.2147/CMAR.S178126. PMID: 30538561; PMCID: PMC6257864

  • Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, Lee CF, Wang YC (2010 Feb) The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 120(2):521-32. https://doi.org/10.1172/JCI40706. Epub 2010 Jan 19. PMID: 20093774; PMCID: PMC2810088

  • Liu TH, Raval A, Chen SS, Matkovic JJ, Byrd JC, Plass C (2006 Jan 15) CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res 66(2):653-658. https://doi.org/10.1158/0008-5472.CAN-05-3712. PMID: 16423993

  • Liu P, Cheng H, Roberts TM, Zhao JJ (2009 Aug) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 8(8):627-44. https://doi.org/10.1038/nrd2926. PMID: 19644473; PMCID: PMC3142564

  • Liu F, Zhao X, Perna F, Wang L, Koppikar P, Abdel-Wahab O, Harr MW, Levine RL, Xu H, Tefferi A, Deblasio A, Hatlen M, Menendez S, Nimer SD (2011 Feb 15) JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation. Cancer Cell 19(2):283-94. https://doi.org/10.1016/j.ccr.2010.12.020. PMID: 21316606; PMCID: PMC4687747

  • Liu Y, Liu F, Yu H, Zhao X, Sashida G, Deblasio A, Harr M, She QB, Chen Z, Lin HK, Di Giandomenico S, Elf SE, Yang Y, Miyata Y, Huang G, Menendez S, Mellinghoff IK, Rosen N, Pandolfi PP, Hedvat CV, Nimer SD (2012 Oct 23) Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus. Sci Signal 5(247):ra77. https://doi.org/10.1126/scisignal.2003199. PMID: 23092893

  • Liu Q, Zheng JM, Chen JK, Yan XL, Chen HM, Nong WX, Huang HQ (2014 Oct) Histone deacetylase 5 promotes the proliferation of glioma cells by upregulation of Notch 1. Mol Med Rep 10(4):2045-2050. https://doi.org/10.3892/mmr.2014.2395. Epub 2014 Jul 18. PMID: 25050565

  • Liu L, Sun L, Li C, Li X, Zhang Y, Yu Y, Xia W (2015) Quantitative detection of methylation of FHIT and BRCA1 promoters in the serum of ductal breast cancer patients. Biomed Mater Eng 26 Suppl 1:S2217-S2222. https://doi.org/10.3233/BME-151527. PMID: 26406001

  • Liu S, Li C, Xin P, Zheng Y, Peng Q, Xu Y, Luo Y, Wu Y, Zhu X (2019 Nov 14) Sonidegib, a smoothened inhibitor, promotes apoptosis and suppresses proliferation of natural Killer/T-cell lymphoma. Med Sci Monit. 25:8579-8586. https://doi.org/10.12659/MSM.918812. PMID: 31724562; PMCID: PMC6873646

  • Liu Y, Yang EJ, Shi C, Mou PK, Zhang B, Wu C, Lyu J, Shim JS (2020 Mar 25) Histone Acetyltransferase (HAT) P300/CBP inhibitors induce synthetic lethality in PTEN-deficient colorectal cancer cells through destabilizing AKT. Int J Biol Sci 16(11):1774-1784. https://doi.org/10.7150/ijbs.42197. PMID: 32398948; PMCID: PMC7211175.19

  • Liu JH, Cao YM, Rong ZP, Ding J, Pan X (2021) Trichostatin A induces autophagy in cervical cancer cells by regulating the PRMT5-STC1-TRPV6-JNK pathway. Pharmacology 106(1-2):60-69. https://doi.org/10.1159/000507937. Epub 2020 Nov 3. PMID: 33142290

  • Locke WJ, Guanzon D, Ma C, Liew YJ, Duesing KR, Fung KYC, Ross JP (2019 Nov 14) DNA methylation cancer biomarkers: translation to the clinic. Front Genet 10:1150. https://doi.org/10.3389/fgene.2019.01150. PMID: 31803237; PMCID: PMC6870840

  • López de Silanes I, Gorospe M, Taniguchi H, Abdelmohsen K, Srikantan S, Alaminos M, Berdasco M, Urdinguio RG, Fraga MF, Jacinto FV, Esteller M (2009 May) The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA. Nucleic Acids Res 37(8):2658-71. https://doi.org/10.1093/nar/gkp123. Epub 2009 Mar 6. PMID: 19270063; PMCID: PMC2677878

  • Lund P, Weisshaupt K, Mikeska T, Jammas D, Chen X, Kuban RJ, Ungethüm U, Krapfenbauer U, Herzel HP, Schäfer R, Walter J, Sers C (2006 Aug 10) Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. Oncogene 25(35):4890-4903. https://doi.org/10.1038/sj.onc.1209502. Epub 2006 Mar 27. PMID: 16568090

  • MacLeod AR, Rouleau J, Szyf M (1995 May 12) Regulation of DNA methylation by the Ras signaling pathway. J Biol Chem 270(19):11327-11337. https://doi.org/10.1074/jbc.270.19.11327. PMID: 7744770

  • Margueron R, Reinberg D (2011 Jan 20) The Polycomb complex PRC2 and its mark in life. Nature 469(7330):343-9. https://doi.org/10.1038/nature09784. PMID: 21248841; PMCID: PMC3760771

  • Marigo V, Davey RA, Zuo Y, Cunningham JM, Tabin CJ (1996 Nov 14) Biochemical evidence that patched is the Hedgehog receptor. Nature 384(6605):176-179. https://doi.org/10.1038/384176a0. PMID: 8906794

  • Masui K, Harachi M, Ikegami S, Yang H, Onizuka H, Yong WH, Cloughesy TF, Muragaki Y, Kawamata T, Arai N, Komori T, Cavenee WK, Mischel PS, Shibata N (2019 Dec 20) mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma. J Biol Chem 294(51):19740-19751. https://doi.org/10.1074/jbc.RA119.011519. Epub 2019 Nov 11. PMID: 31712311; PMCID: PMC6926466

  • Masui K, Harachi M, Cavenee WK, Mischel PS, Shibata N (2020 May 28) mTOR complex 2 is an integrator of cancer metabolism and epigenetics. Cancer Lett 478:1-7. https://doi.org/10.1016/j.canlet.2020.03.001. Epub 2020 Mar 5. PMID: 32145344

  • Mei FC, Young TW, Liu J, Cheng X (2006 Mar) RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells. FASEB J 20(3):497-499. https://doi.org/10.1096/fj.05-4586fje. Epub 2005 Dec 29. PMID: 16384911

  • Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA 3rd, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY (2021 Jun 2) Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; results of a first-in-human phase I trial. Clin Cancer Res https://doi.org/10.1158/1078-0432.CCR-21-0611. Epub ahead of print. PMID: 34078652

  • Mill P, Mo R, Hu MC, Dagnino L, Rosenblum ND, Hui CC (2005 Aug) Shh controls epithelial proliferation via independent pathways that converge on N-Myc. Dev Cell. 9(2):293-303. https://doi.org/10.1016/j.devcel.2005.05.009. PMID: 16054035

  • Miller JR (2002) The Wnts. Genome Biol 3(1):REVIEWS3001. https://doi.org/10.1186/gb-2001-3-1-reviews3001. Epub 2001 Dec 28. PMID: 11806834; PMCID: PMC150458

  • Miller AL, Fehling SC, Garcia PL, Gamblin TL, Council LN, van Waardenburg RCAM, Yang ES, Bradner JE, Yoon KJ (2019 Jun) The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors. EBioMedicine 44:419-430. https://doi.org/10.1016/j.ebiom.2019.05.035. Epub 2019 May 22. PMID: 31126889; PMCID: PMC6604668

  • Mirmohammadsadegh A, Marini A, Nambiar S, Hassan M, Tannapfel A, Ruzicka T, Hengge UR (2006 Jul 1) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res. 66(13):6546-6552. https://doi.org/10.1158/0008-5472.CAN-06-0384. PMID: 16818626

  • Mizuno Y, Maemura K, Tanaka Y, Hirata A, Futaki S, Hamamoto H, Taniguchi K, Hayashi M, Uchiyama K, Shibata MA, Otsuki Y, Kondo Y (2018 May) Expression of delta-like 3 is downregulated by aberrant DNA methylation and histone modification in hepatocellular carcinoma. Oncol Rep 39(5):2209-2216. https://doi.org/10.3892/or.2018.6293. Epub 2018 Mar 5. PMID: 29512761

  • Moon RT, Kohn AD, De Ferrari GV, Kaykas A (2004 Sep) WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5(9):691-701. https://doi.org/10.1038/nrg1427. PMID: 15372092

  • Mosimann C, Hausmann G, Basler K (2009 Apr) Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol 10(4):276–286. https://doi.org/10.1038/nrm2654

  • Moskalev EA, Luckert K, Vorobjev IA, Mastitsky SE, Gladkikh AA, Stephan A, Schrenk M, Kaplanov KD, Kalashnikova OB, Pötz O, Joos TO, Hoheisel JD (2012 Jun 6) Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia. BMC Cancer 12:213. https://doi.org/10.1186/1471-2407-12-213. PMID: 22672427; PMCID: PMC3489542

  • Munafó DB, Colombo MI (2002 Jul) Induction of autophagy causes dramatic changes in the subcellular distribution of GFP-Rab24. Traffic 3(7):472-482. https://doi.org/10.1034/j.1600-0854.2002.30704.x. PMID: 12047555

  • Mungamuri SK, Murk W, Grumolato L, Bernstein E, Aaronson SA (2013 Oct 31) Chromatin modifications sequentially enhance ErbB2 expression in ErbB2-positive breast cancers. Cell Rep 5(2):302-13. https://doi.org/10.1016/j.celrep.2013.09.009. Epub 2013 Oct 10. PMID: 24120871; PMCID: PMC3905738

  • Nakamura K, Nakabayashi K, Htet Aung K, Aizawa K, Hori N, Yamauchi J, Hata K, Tanoue A (2015 Mar 23) DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status. PLoS One 10(3):e0120545. https://doi.org/10.1371/journal.pone.0120545. PMID: 25799509; PMCID: PMC4370694

  • Nelson WJ, Nusse R (2004 Mar 5) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303(5663):1483-7. https://doi.org/10.1126/science.1094291. PMID: 15001769; PMCID: PMC3372896.

  • Niehrs C (2006 Dec 4) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25(57):7469-7481. https://doi.org/10.1038/sj.onc.1210054. PMID: 17143291

  • Noda H, Kato Y, Yoshikawa H, Arai M, Togashi K, Nagai H, Konishi F, Miki Y (2006 Jun) Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers. J Exp Clin Cancer Res 25(2):235-242. PMID: 16918136

    Google Scholar 

  • Nowell CS, Radtke F (2017 Mar) Notch as a tumour suppressor. Nat Rev Cancer 17(3):145-159. https://doi.org/10.1038/nrc.2016.145. Epub 2017 Feb 3. PMID: 28154375

  • Okamoto M, Udagawa N, Uehara S, Maeda K, Yamashita T, Nakamichi Y, Kato H, Saito N, Minami Y, Takahashi N, Kobayashi Y (2014 Mar 27) Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis. Sci Rep 4:4493. https://doi.org/10.1038/srep04493. PMID: 24670389; PMCID: PMC3967152

  • Okano M, Bell DW, Haber DA, Li E (1999 Oct 29) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247-257. https://doi.org/10.1016/s0092-8674(00)81656-6. PMID: 10555141

  • Olkkonen VM, Stenmark H (1997) Role of RabGTPases in membrane traffic. Int Rev Cytol. 176:1-85. https://doi.org/10.1016/s0074-7696(08)61608-3. PMID: 9394917

  • Pak S, Park S, Kim Y, Park JH, Park CH, Lee KJ, Kim CS, Ahn H (2019 Aug 6) The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res 38(1):342. https://doi.org/10.1186/s13046-019-1342-5. Erratum in: J Exp Clin Cancer Res. 2019 Oct 31;38(1):440. PMID: 31387608; PMCID: PMC6685284

  • Parker DS, Ni YY, Chang JL, Li J, Cadigan KM (2008 Mar) Wingless signaling induces widespread chromatin remodeling of target loci. Mol Cell Biol 28(5):1815–1828. https://doi.org/10.1128/MCB.01230-07. Epub 2007 Dec 26; PMCID: PMC2258762

  • Palakurthy RK, Wajapeyee N, Santra MK, Gazin C, Lin L, Gobeil S, Green MR (2009 Oct 23) Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol Cell. 36(2):219–30. https://doi.org/10.1016/j.molcel.2009.10.009. PMID: 19854132; PMCID: PMC2776651

  • Pan Y, Liu G, Zhou F, Su B, Li Y (2018 Feb) DNA methylation profiles in cancer diagnosis and therapeutics. Clin Exp Med 18(1):1-14. https://doi.org/10.1007/s10238-017-0467-0. Epub 2017 Jul 27. PMID: 28752221.

  • Peli J, Schröter M, Rudaz C, Hahne M, Meyer C, Reichmann E, Tschopp J (1999 Apr 1) Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. EMBO J 18(7):1824-31. https://doi.org/10.1093/emboj/18.7.1824. PMID: 10202146; PMCID: PMC1171268.

  • Piazzi G, Bazzoli F, Ricciardiello L (2012 Dec 1) Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle 11(23):4323-7. https://doi.org/10.4161/cc.22388. Epub 2012 Oct 19. PMID: 23085543; PMCID: PMC3552914

  • Polakis P (2000 Aug 1) Wnt signaling and cancer. Genes Dev 14(15):1837-1851. PMID: 10921899

    Google Scholar 

  • Ponnurangam S, Dandawate PR, Dhar A, Tawfik OW, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G, Umar S, Weir SJ, Sugumar A, Jensen RA, Padhye SB, Balakrishnan A, Anant S, Subramaniam D (2016 Jan 19) Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Oncotarget 7(3):3217–32. https://doi.org/10.18632/oncotarget.6560. PMID: 26673007; PMCID: PMC4823101

  • Prasad CP, Mirza S, Sharma G, Prashad R, DattaGupta S, Rath G, Ralhan R (2008 Aug 29) Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci 83(9–10):318-325. https://doi.org/10.1016/j.lfs.2008.06.019. Epub 2008 Jul 1. PMID: 18662704

  • Pruitt K, Ulkü AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM (2005 Jun 17) Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem 280(24):23363-23370. https://doi.org/10.1074/jbc.M503083200. Epub 2005 Apr 14. PMID: 15831492.

  • Radtke F, Raj K (2003 Oct) The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 3(10):756-767. https://doi.org/10.1038/nrc1186. PMID: 14570040

  • Reifenberger J, Knobbe CB, Sterzinger AA, Blaschke B, Schulte KW, Ruzicka T, Reifenberger G (2004 Apr 10) Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Int J Cancer 109(3):377-384. https://doi.org/10.1002/ijc.11722. PMID: 14961576

  • Reya T, Clevers H (2005 Apr 14) Wnt signalling in stem cells and cancer. Nature 434(7035):843-850. https://doi.org/10.1038/nature03319. PMID: 15829953

  • Rimkus TK, Carpenter RL, Qasem S, Chan M, Lo HW (2016 Feb 15) Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Cancers (Basel) 8(2):22. https://doi.org/10.3390/cancers8020022. PMID: 26891329; PMCID: PMC4773745

  • Riquelme E, Behrens C, Lin HY, Simon G, Papadimitrakopoulou V, Izzo J, Moran C, Kalhor N, Lee JJ, Minna JD, Wistuba II (2016 Feb 1) Modulation of EZH2 expression by MEK-ERK or PI3K-AKT signaling in lung cancer is dictated by different KRAS oncogene mutations. Cancer Res 76(3):675-85. https://doi.org/10.1158/0008-5472.CAN-15-1141. Epub 2015 Dec 16. PMID: 26676756; PMCID: PMC4738155

  • Sanaei M, Kavoosi F (2020 Sep 10) Effect of 5-aza-2′-deoxycytidine on estrogen receptor alpha/beta and DNA methyltransferase 1 genes expression, apoptosis induction, and cell growth prevention of the colon cancer HT 29 Cell Line. Int J Prev Med 11:147. https://doi.org/10.4103/ijpvm.IJPVM_140_19. PMID: 33209217; PMCID: PMC7643574

  • Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M (2003 Jul 1) Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 63(13):3735-3742. PMID: 12839967

    Google Scholar 

  • Schöffski P, Cresta S, Mayer IA, Wildiers H, Damian S, Gendreau S, Rooney I, Morrissey KM, Spoerke JM, Ng VW, Singel SM, Winer E (2018 Sep 5) A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer. Breast Cancer Res 20(1):109. https://doi.org/10.1186/s13058-018-1015-x. PMID: 30185228; PMCID: PMC6125885

  • Semënov MV, Tamai K, Brott BK, Kühl M, Sokol S, He X (2001 Jun 26) Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11(12):951-961. https://doi.org/10.1016/s0960-9822(01)00290-1. PMID: 11448771

  • Senapati P, Kato H, Lee M, Leung A, Thai C, Sanchez A, Gallagher EJ, LeRoith D, Seewaldt VL, Ann DK, Schones DE (2019 Jul 17) Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer. Epigenetics Chromatin 12(1):44. https://doi.org/10.1186/s13072-019-0290-9. PMID: 31315653; PMCID: PMC6636093

  • Serman L, Nikuseva Martic T, Serman A, Vranic S (2014 Nov 12) Epigenetic alterations of the Wnt signaling pathway in cancer: a mini review. Bosn J Basic Med Sci 14(4):191-4. https://doi.org/10.17305/bjbms.2014.4.205. PMID: 25428669; PMCID: PMC4333971

  • Shahi MH, Lorente A, Castresana JS (2008 Mar) Hedgehog signalling in medulloblastoma, glioblastoma and neuroblastoma. Oncol Rep 19(3):681-688. PMID: 18288402

    Google Scholar 

  • Shao B, Feng Y, Zhang H, Yu F, Li Q, Tan C, Xu H, Ying J, Li L, Yang D, Peng W, Tang J, Li S, Ren G, Tao Q, Xiang T (2018 Feb) The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer. J Cell Mol Med 22(2):1257-1271. https://doi.org/10.1111/jcmm.13404. Epub 2017 Nov 29. PMID: 29193730; PMCID: PMC5783842

  • Sharma S, Kelly TK, Jones PA (2010 Jan) Epigenetics in cancer. Carcinogenesis 31(1):27-36. https://doi.org/10.1093/carcin/bgp220. Epub 2009 Sep 13. PMID: 19752007; PMCID: PMC2802667

  • Sharma ND, Nickl CK, Kang H, Ornatowski W, Brown R, Ness SA, Loh ML, Mullighan CG, Winter SS, Hunger SP, Cannon JL, Matlawska-Wasowska K (2019 Jun) Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia. Cancer Sci 110(6):1931-1946. https://doi.org/10.1111/cas.14021. Epub 2019 May 3. PMID: 30974024; PMCID: PMC6549933

  • Shen YQ, Guerra-Librero A, Fernandez-Gil BI, Florido J, García-López S, Martinez-Ruiz L, Mendivil-Perez M, Soto-Mercado V, Acuña-Castroviejo D, Ortega-Arellano H, Carriel V, Diaz-Casado ME, Reiter RJ, Rusanova I, Nieto A, López LC, Escames G (2018 Apr) Combination of melatonin and rapamycin for head and neck cancer therapy: suppression of AKT/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. J Pineal Res 64(3). https://doi.org/10.1111/jpi.12461. Epub 2018 Jan 9. PMID: 29247557.

  • Shu J, Jelinek J, Chang H, Shen L, Qin T, Chung W, Oki Y, Issa JP (2006 May 15) Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Res 66(10):5077-5084. https://doi.org/10.1158/0008-5472.CAN-05-2629. PMID: 16707430

  • Sierra J, Yoshida T, Joazeiro CA, Jones KA (2006 Mar 1) The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20(5):586–600. https://doi.org/10.1101/gad.1385806. PMCID: PMC1410807

  • Song Y, Li ZX, Liu X, Wang R, Li LW, Zhang Q (2017 Jul) The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation. Tumour Biol 39(7):1010428317712617. https://doi.org/10.1177/1010428317712617

  • Spangle JM, Dreijerink KM, Groner AC, Cheng H, Ohlson CE, Reyes J, Lin CY, Bradner J, Zhao JJ, Roberts TM, Brown M (2016 Jun 21) PI3K/AKT signaling regulates H3K4 methylation in breast cancer. Cell Rep 15(12):2692-704. https://doi.org/10.1016/j.celrep.2016.05.046. Epub 2016 Jun 9. PMID: 27292631; PMCID: PMC5094353

  • Staal FJ, Clevers HC (2005 Jan) WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 5(1):21-30. https://doi.org/10.1038/nri1529. PMID: 15630426

  • Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G, Lo-Coco F, Klisovic RB, Wei A, Sierra J, Sanz MA, Brandwein JM, de Witte T, Niederwieser D, Appelbaum FR, Medeiros BC, Tallman MS, Krauter J, Schlenk RF, Ganser A, Serve H, Ehninger G, Amadori S, Larson RA, Döhner H (2017 Aug 3) Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation. N Engl J Med 377(5):454-464. https://doi.org/10.1056/NEJMoa1614359. Epub 2017 Jun 23. PMID: 28644114; PMCID: PMC5754190

  • Strahl BD, Allis CD (2000 Jan 6) The language of covalent histone modifications. Nature 403(6765):41-45. https://doi.org/10.1038/47412. PMID: 10638745

  • Sun L, Chen B, Wu J, Jiang C, Fan Z, Feng Y, Xu Y (2020 Sep 11) Epigenetic regulation of a disintegrin and metalloproteinase (ADAM) transcription in colorectal cancer cells: involvement of β-catenin, BRG1, and KDM4. Front Cell Dev Biol 8:581692. https://doi.org/10.3389/fcell.2020.581692. PMCID: PMC7517301

  • Surana R, Sikka S, Cai W, Shin EM, Warrier SR, Tan HJ, Arfuso F, Fox SA, Dharmarajan AM, Kumar AP (2014 Jan) Secreted frizzled related proteins: implications in cancers. Biochim Biophys Acta 1845(1):53-65. https://doi.org/10.1016/j.bbcan.2013.11.004. Epub 2013 Dec 5. PMID: 24316024

  • Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB (2004 Apr) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36(4):417-422. https://doi.org/10.1038/ng1330. Epub 2004 Mar 14. PMID: 15034581

  • Tada M, Kanai F, Tanaka Y, Tateishi K, Ohta M, Asaoka Y, Seto M, Muroyama R, Fukai K, Imazeki F, Kawabe T, Yokosuka O, Omata M (2008 Jun 15) Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma. Clin Cancer Res 14(12):3768-3776. https://doi.org/10.1158/1078-0432.CCR-07-1181. PMID: 18559595

  • Taipale J, Beachy PA (2001 May 17) The Hedgehog and Wnt signalling pathways in cancer. Nature 411(6835):349-354. https://doi.org/10.1038/35077219. PMID: 11357142

  • Tan D, Tang P, Huang J, Zhang J, Zhou W, Walker AM. Expression of a constitutively active prolactin receptor causes histone trimethylation of the p53 gene in breast cancer. Chin Med J (Engl). 2014;127(6):1077-1083. PMID: 24622438

    Google Scholar 

  • Tan AHY, Tu W, McCuaig R, Hardy K, Donovan T, Tsimbalyuk S, Forwood JK, Rao S (2019 Jun 12) Lysine-specific histone demethylase 1A regulates macrophage polarization and checkpoint molecules in the tumor microenvironment of triple-negative breast cancer. Front Immunol 10:1351. https://doi.org/10.3389/fimmu.2019.01351. PMID: 31249575; PMCID: PMC6582666

  • ten Haaf A, Franken L, Heymann C, von Serenyi S, Cornelissen C, de Hoon JP, Veeck J, Lüscher B, Knüchel R, Dahl E (2011 Apr) Paradox of sonic hedgehog (SHH) transcriptional regulation: alternative transcription initiation overrides the effect of downstream promoter DNA methylation. Epigenetics 6(4):465-477. https://doi.org/10.4161/epi.6.4.14952. Epub 2011 Apr 1. PMID: 21372638.

  • Terasaki H, Saitoh T, Shiokawa K, Katoh M (2002 Feb) Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway. Int J Mol Med 9(2):107-112. PMID: 11786918

    Google Scholar 

  • Tham C, Chew M, Soong R, Lim J, Ang M, Tang C, Zhao Y, Ong SY, Liu Y (2014 Oct 15) Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. Cancer 120(20):3131-3141. https://doi.org/10.1002/cncr.28802. Epub 2014 Jun 12 PMID: 24925595

  • Thomas SJ, Snowden JA, Zeidler MP, Danson SJ (2015 Jul 28) The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer 113(3):365-71. https://doi.org/10.1038/bjc.2015.233. Epub 2015 Jul 7. PMID: 26151455; PMCID: PMC4522639

  • Thorpe LM, Yuzugullu H, Zhao JJ (2015 Jan) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 15(1):7-24. https://doi.org/10.1038/nrc3860. PMID: 25533673; PMCID: PMC4384662

  • Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y (2003 Sep 1) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162(5):899-908. https://doi.org/10.1083/jcb.200303158. PMID: 12952940; PMCID: PMC2172823

  • Tsai CH, Li CH, Liao PL, Chang YW, Cheng YW, Kang JJ (2020 Feb) Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions. Biochim Biophys Acta Mol Cell Res 1867(2):118564. https://doi.org/10.1016/j.bbamcr.2019.118564. Epub 2019 Oct 28. PMID: 31672612

  • Tzao C, Jin JS, Chen BH, Chung HY, Chang CC, Hsu TY, Sun GH (2014 Sep-Oct) Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo. Dis Esophagus 27(7):693-702. https://doi.org/10.1111/dote.12127. Epub 2013 Sep 4. PMID: 24033428

  • Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM (2003 Aug 1) Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 63(15):4547-4551. PMID: 12907630

    Google Scholar 

  • Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP, Cumberledge S, Rubin JS (2000 Feb 11) Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275(6):4374-4382. https://doi.org/10.1074/jbc.275.6.4374. PMID: 10660608

  • Vadla R, Haldar D (2018) Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation. Cell Cycle 17(1):110-123. https://doi.org/10.1080/15384101.2017.1404207. Epub 2018 Jan 8. PMID: 29143563; PMCID: PMC5815439

  • Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E (2008 Nov 6) Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol Cancer 7:83. https://doi.org/10.1186/1476-4598-7-83. PMID: 18990230; PMCID: PMC2613402

  • Villanueva L, Álvarez-Errico D, Esteller M (2020 Aug) The contribution of epigenetics to cancer immunotherapy. Trends Immunol 41(8):676-691. https://doi.org/10.1016/j.it.2020.06.002. Epub 2020 Jul 2. PMID: 32622854

  • Visser HP, Gunster MJ, Kluin-Nelemans HC, Manders EM, Raaphorst FM, Meijer CJ, Willemze R, Otte AP (2001 Mar) The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol 112(4):950-958. https://doi.org/10.1046/j.1365-2141.2001.02641.x. PMID: 11298590

  • Wajapeyee N, Malonia SK, Palakurthy RK, Green MR (2013 Oct 15) Oncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressors. Genes Dev 27(20):2221-6. https://doi.org/10.1101/gad.227413.113. Epub 2013 Oct 8. PMID: 24105743; PMCID: PMC3814642.

  • Wang LH, Choi YL, Hua XY, Shin YK, Song YJ, Youn SJ, Yun HY, Park SM, Kim WJ, Kim HJ, Choi JS, Kim SH (2006 May) Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions. Mod Pathol 19(5):675–683. https://doi.org/10.1038/modpathol.3800573

  • Wang X, Venugopal C, Manoranjan B, McFarlane N, O’Farrell E, Nolte S, Gunnarsson T, Hollenberg R, Kwiecien J, Northcott P, Taylor MD, Hawkins C, Singh SK (2012a Jan 12) Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells. Oncogene 31(2):187-199. doi: https://doi.org/10.1038/onc.2011.232. Epub 2011 Jun 20. PMID: 21685941

  • Wang ZK, Liu J, Liu C, Wang FY, Chen CY, Zhang XH (2012b Oct) Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas. J Gastroenterol Hepatol 27(10):1629-1634. https://doi.org/10.1111/j.1440-1746.2012.07219.x. PMID: 22741528

  • Wang S, Dong Y, Zhang Y, Wang X, Xu L, Yang S, Li X, Dong H, Xu L, Su L, Ng SS, Chang Z, Sung JJ, Zhang X, Yu J (2015 May 14) DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer. Oncogene 34(20):2575-85. https://doi.org/10.1038/onc.2014.201. Epub 2014 Jul 14. PMID: 25023701; PMCID: PMC4761644.

  • Wang D, Xu J, Liu B, He X, Zhou L, Hu X, Qiao F, Zhang A, Xu X, Zhang H, Wicha MS, Zhang L, Shao ZM, Liu S (2018 Feb) IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer. Cell Death Differ 25(2):330-339. https://doi.org/10.1038/cdd.2017.162. Epub 2017 Oct 13. PMID: 29027990; PMCID: PMC5762847.

  • Wang G, Long J, Gao Y, Zhang W, Han F, Xu C, Sun L, Yang SC, Lan J, Hou Z, Cai Z, Jin G, Hsu CC, Wang YH, Hu J, Chen TY, Li H, Lee MG, Lin HK (2019 Feb) SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis. Nat Cell Biol 21(2):214-225. https://doi.org/10.1038/s41556-018-0266-1. Epub 2019 Jan 28. PMID: 30692626; PMCID: PMC6414065.

  • Wei H, Wang Y, Gale RP, Lin D, Zhou C, Liu B, Qiu S, Gu R, Li Y, Zhao X, Wei S, Gong B, Liu K, Gong X, Liu Y, Zhang G, Song Z, Wang Y, Li W, Mi Y, Wang J (2020 Jul 1) Randomized trial of intermediate-dose cytarabine in induction and consolidation therapy in adults with acute myeloid leukemia. Clin Cancer Res 26(13):3154-3161. https://doi.org/10.1158/1078-0432.CCR-19-3433. Epub 2020 Feb 6. PMID: 32029439

  • Wei KL, Chou JL, Chen YC, Low JT, Lin GL, Liu JL, Chang TS, Chen WM, Hsieh YY, Yan PS, Chuang YM, Lin JMJ, Wu SF, Chiang MK, Li C, Wu CS, Chan MWY (2021 Feb 25) Epigenetic silencing of STAT3-targeted miR-193a, by constitutive activation of JAK/STAT signaling, leads to tumor progression through overexpression of YWHAZ in gastric cancer. Front Oncol 11:575667. https://doi.org/10.3389/fonc.2021.575667. PMID: 33718136; PMCID: PMC7951088.

  • Wend P, Fang L, Zhu Q, Schipper JH, Loddenkemper C, Kosel F, Brinkmann V, Eckert K, Hindersin S, Holland JD, Lehr S, Kahn M, Ziebold U, Birchmeier W (2013 Jul 17) Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. EMBO J 32(14):1977–1989. https://doi.org/10.1038/emboj.2013.127. Epub 2013 Jun 4. PMCID: PMC3715856

  • Widelitz R (2005 Jun) Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 23(2):111-116. https://doi.org/10.1080/08977190500125746. PMID: 16019432

  • Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY, Koeffler HP (2007 Oct) Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Treat 105(2):139-155. https://doi.org/10.1007/s10549-006-9440-4. Epub 2007 Feb 13. PMID: 17295047

  • Wu Y, Kikuchi S, Yan H, Zhang W, Rosenbaum H, Iniguez AL, Jiang J (2011 Nov) Euchromatic subdomains in rice centromeres are associated with genes and transcription. Plant Cell 23(11):4054-64. https://doi.org/10.1105/tpc.111.090043. Epub 2011 Nov 11. PMID: 22080597; PMCID: PMC3246336.

  • Wu CS, Wei KL, Chou JL, Lu CK, Hsieh CC, Lin JM, Deng YF, Hsu WT, Wang HM, Leung CH, Ma DL, Li C, Chan MW (2016a Sep 2) Aberrant JAK/STAT signaling suppresses TFF1 and TFF2 through epigenetic silencing of GATA6 in gastric cancer. Int J Mol Sci 17(9):1467. https://doi.org/10.3390/ijms17091467. PMID: 27598141; PMCID: PMC5037745

  • Wu J, Keng VW, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, Dombi E, Levy DE, Huang G, Cancelas JA, Stemmer-Rachamimov AO, Spinner RJ, Largaespada DA, Ratner N (2016b Mar 1) Insertional mutagenesis identifies a STAT3/Arid1b/β-catenin pathway driving neurofibroma initiation. Cell Rep 14(8):1979-90. https://doi.org/10.1016/j.celrep.2016.01.074. Epub 2016 Feb 18. PMID: 26904939; PMCID: PMC4782770

  • Wu Z, Yang Z, Dai Y, Zhu Q, Chen LA (2019 Jul 1) Update on liquid biopsy in clinical management of non-small cell lung cancer. Onco Targets Ther 12:5097-5109. https://doi.org/10.2147/OTT.S203070. PMID: 31303765; PMCID: PMC6611714.

  • Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J, Barbera AJ, Zheng L, Zhang H, Huang S, Min J, Nicholson T, Chen T, Xu G, Shi Y, Zhang K, Shi YG (2011 May 20) Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 42(4):451-64. https://doi.org/10.1016/j.molcel.2011.04.005. Epub 2011 Apr 21. PMID: 21514197; PMCID: PMC3099128.

  • Xu H, Xiao Q, Fan Y, Xiang T, Li C, Li C, Li S, Hui T, Zhang L, Li H, Li L, Ren G (2017 Jun) Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF-κB signaling. Cancer Med 6(6):1399-1408. https://doi.org/10.1002/cam4.1076. Epub 2017 May 15. PMID: 28503860; PMCID: PMC5463072.

  • Yang X, Han H, De Carvalho DD, Lay FD, Jones PA, Liang G (2014 Oct 13) Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 26(4):577-90. https://doi.org/10.1016/j.ccr.2014.07.028. Epub 2014 Sep 25. PMID: 25263941; PMCID: PMC4224113.

  • Yang H, Zhou J, Mi J, Ma K, Fan Y, Ning J, Wang C, Wei X, Zhao H, Li E (2015 Oct) HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma. Oncol Rep 34(4):1681-91. https://doi.org/10.3892/or.2015.4194. Epub 2015 Aug 10. PMID: 26260613; PMCID: PMC4564083.

  • Yeh CM, Chang LY, Lin SH, Chou JL, Hsieh HY, Zeng LH, Chuang SY, Wang HW, Dittner C, Lin CY, Lin JM, Huang YT, Ng EK, Cheng AS, Wu SF, Lin J, Yeh KT, Chan MW (2016 Aug 16) Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer. Sci Rep 6:31690. https://doi.org/10.1038/srep31690. PMID: 27528092; PMCID: PMC4985659.

  • Yuan YH, Wang HY, Lai Y, Zhong W, Liang WL, Yan FD, Yu Z, Chen JK, Lin Y (2019 Jan 25) Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway. Cell Commun Signal 17(1):9. https://doi.org/10.1186/s12964-018-0316-0. PMID: 30683109; PMCID: PMC6347846.

  • Zamani M, Hosseini SV, Mokarram P (2018 Mar) Epigenetic biomarkers in colorectal cancer: premises and prospects. Biomarkers 23(2):105-114. https://doi.org/10.1080/1354750X.2016.1252961. Epub 2016 Nov 10. PMID: 27788596

  • Zampieri M, Ciccarone F, Palermo R, Cialfi S, Passananti C, Chiaretti S, Nocchia D, Talora C, Screpanti I, Caiafa P (2014 Sep). The epigenetic factor BORIS/CTCFL regulates the NOTCH3 gene expression in cancer cells. Biochim Biophys Acta 1839(9):813-825. https://doi.org/10.1016/j.bbagrm.2014.06.017. Epub 2014 Jun 28. PMID: 24984200

  • Zavras AI, Pitiphat W, Wu T, Cartsos V, Lam A, Douglass CW, Diehl SR (2003 Jan 15) Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans. Cancer Res 63(2):296-297. PMID: 12543777

    Google Scholar 

  • Zhang W, Glöckner SC, Guo M, Machida EO, Wang DH, Easwaran H, Van Neste L, Herman JG, Schuebel KE, Watkins DN, Ahuja N, Baylin SB (2008 Apr 15) Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res 68(8):2764-72. https://doi.org/10.1158/0008-5472.CAN-07-6349. Erratum in: Cancer Res. 2008 Jul 15;68(14):6030. PMID: 18413743; PMCID: PMC2823123.

  • Zhang Y, Huang S, Dong W, Li L, Feng Y, Pan L, Han Z, Wang X, Ren G, Su D, Huang B, Lu J (2009 May 8) SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 277(1):29–37

    Google Scholar 

  • Zhang Y, Xu H, Mu J, Guo S, Ye L, Li D, Peng W, He X, Xiang T (2019 May) Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression. J Cell Physiol 234(5):6965-6975. https://doi.org/10.1002/jcp.27439. Epub 2018 Nov 11. PMID: 30417422

  • Zhang W, Zhang Y, Tu T, Schmull S, Han Y, Wang W, Li H (2020 Sep 17) Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGFβ1 induced lung and tumor fibrosis. Cell Death Dis 11(9):765. https://doi.org/10.1038/s41419-020-02916-w. PMID: 32943605; PMCID: PMC7499263.

  • Zhou W, Tian D, He J, Wang Y, Zhang L, Cui L, Jia L, Zhang L, Li L, Shu Y, Yu S, Zhao J, Yuan X, Peng S (2016 Apr 12) Repeated PM2.5 exposure inhibits BEAS-2B cell P53 expression through ROS-Akt-DNMT3B pathway-mediated promoter hypermethylation. Oncotarget 7(15):20691-703. https://doi.org/10.18632/oncotarget.7842. PMID: 26942697; PMCID: PMC4991485.

  • Zou C, Fan J, He M, Xu Y, Wang K, Cai Y, Li M (2019 May 15) Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling. Exp Cell Res 378(2):139-148. doi: https://doi.org/10.1016/j.yexcr.2019.02.025. Epub 2019 Feb 28. PMID: 30826396

  • Zuo Y, Song Y (2013 Dec) Detection and analysis of the methylation status of PTCH1 gene involved in the hedgehog signaling pathway in a human gastric cancer cell line. Exp Ther Med 6(6):1365-1368. https://doi.org/10.3892/etm.2013.1334. Epub 2013 Oct 9. PMID: 24255663; PMCID: PMC3829737.

  • Zuo T, Liu TM, Lan X, Weng YI, Shen R, Gu F, Huang YW, Liyanarachchi S, Deatherage DE, Hsu PY, Taslim C, Ramaswamy B, Shapiro CL, Lin HJ, Cheng AS, Jin VX, Huang TH (2011 Mar 1) Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. Cancer Res 71(5):1752-62. https://doi.org/10.1158/0008-5472.CAN-10-3573. Epub 2011 Jan 7. PMID: 21216892; PMCID: PMC3048165.

Download references

Author information

Author notes

  1. Snigdha Samanta and Rumpa Mahata contributed equally with all other contributors.

Authors and Affiliations

  1. Molecular Oncology Laboratory, National Centre for Cell Science, NCCS Complex, S. P. Pune University Campus, Ganeshkhind Road, Pune, Maharashtra, India

    Snigdha Samanta, Rumpa Mahata & Manas Kumar Santra

  2. Department of Biotechnology, Savitribai Phule Pune University, Pune, Maharashtra, India

    Snigdha Samanta & Rumpa Mahata

Authors
  1. Snigdha Samanta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rumpa Mahata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Manas Kumar Santra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manas Kumar Santra .

Editor information

Editors and Affiliations

  1. Transcription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Bangalore, India

    Tapas Kumar Kundu

  2. Biophysics and Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata, India

    Chandrima Das

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Samanta, S., Mahata, R., Santra, M.K. (2022). The Cross-Talk between Epigenetic Gene Regulation and Signaling Pathways Regulates Cancer Pathogenesis. In: Kundu, T.K., Das, C. (eds) Metabolism and Epigenetic Regulation: Implications in Cancer. Subcellular Biochemistry, vol 100. Springer, Cham. https://doi.org/10.1007/978-3-031-07634-3_13

Download citation

Publish with us

Policies and ethics

Search

Navigation